BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Collazos J, Valle-Garay E, Suárez-Zarracina T, Montes AH, Cartón JA, Asensi V. Matrix metalloproteases and their tissue inhibitors in non-alcoholic liver fibrosis of human immunodeficiency virus-infected patients. World J Virol 2017; 6(2): 36-45 [PMID: 28573088 DOI: 10.5501/wjv.v6.i2.36]
URL: https://www.wjgnet.com/2220-3249/full/v6/i2/36.htm
Number Citing Articles
1
Jian‐Wei Liu, Dong‐Qiong Chen. Correlations of MMP‐2 and MMP‐9 gene polymorphisms with the risk of hepatopulmonary syndrome in cirrhotic patients: A case‐control studyThe Kaohsiung Journal of Medical Sciences 2018; 34(11): 634 doi: 10.1016/j.kjms.2018.06.006
2
Lindsay T Fourman, Takara L Stanley, Mollie W Ockene, Colin M McClure, Mabel Toribio, Kathleen E Corey, Raymond T Chung, Martin Torriani, David E Kleiner, Colleen M Hadigan, Steven K Grinspoon. Proteomic Analysis of Hepatic Fibrosis in Human Immunodeficiency Virus–Associated Nonalcoholic Fatty Liver Disease Demonstrates Up-regulation of Immune Response and Tissue Repair PathwaysThe Journal of Infectious Diseases 2023; 227(4): 565 doi: 10.1093/infdis/jiac475
3
Ryan J. Dashek, Connor Diaz, Bysani Chandrasekar, R. Scott Rector. The Role of RECK in Hepatobiliary Neoplasia Reveals Its Therapeutic Potential in NASHFrontiers in Endocrinology 2021; 12 doi: 10.3389/fendo.2021.770740
4
Laura Pérez-Is, Julio Collazos, Belén de la Fuente, Luis Morano, Maria Rivas-Carmenado, Manuel Rodriguez, Adolfo Romero-Favela, Galilea de Jesús Fonseca–González, Santiago Melón, Eulalia Valle-Garay, Víctor Asensi. 24-month decline of non-invasive liver fibrosis markers in HCV-mono and HCV/HIV coinfection after direct-acting antiviral therapyScientific Reports 2022; 12(1) doi: 10.1038/s41598-022-07548-y